DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques. (Q39047929)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 December 2013

Language	Label	Description	Also known as
English	DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.	scientific article published on 6 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1 reference

based on heuristic

inferred from title

Niranjan Y Sardesai

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

N Obeng-Adjei

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

N A Hutnick

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

J Yan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

J S Chu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

D J F Myles

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M P Morrow

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

D B Weiner

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

6 December 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Cancer Gene Therapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

652-662

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

https://scigraph.springernature.com/pub.10.1038/cgt.2013.65

0 references

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Correlation between hepatitis B virus genotypes and clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Hepatitis B virus infection, its sequelae, and prevention by vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Immunisation against hepatitis B in man

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Hepatitis B virus infection: epidemiology and vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Cutting edge: rapid in vivo killing by memory CD8 T cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Long-lasting memory T cell responses following self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Therapeutic vaccination and novel strategies to treat chronic HBV infection

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

To kill or to cure: options in host defense against viral infection.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

DNA vaccines: ready for prime time?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

21 January 2018

Cellular and humoral immune response to a third generation hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic efficacy of hepatitis B surface antigen–antibodies-recombinant DNA composite in HBsAg transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.65

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2013.65

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24310062%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39047929&oldid=1455614037"